-
EMA and ECDC update on COVID-19 vaccination
EMA and ECDC update on COVID-19 vaccination
-
EMA and ECDC update on COVID-19 vaccination
EMA and ECDC update on COVID-19 vaccination
EMA and ECDC have published a second joint statement on the current COVID-19 situation and the importance of full vaccination to protect against disease caused by the Delta variant
-
Simultaneous National Scientific Advice extended
Simultaneous National Scientific Advice extended
-
Simultaneous National Scientific Advice extended
Simultaneous National Scientific Advice extended
The pilot for Simultaneous National Scientific Advice (SNSA) has been extended to the end of 2021. SNSA allows innovators to access scientific advice simultaneously in EU Member States.
-
Six-month countdown to go-live for CTIS
Six-month countdown to go-live for CTIS
-
Six-month countdown to go-live for CTIS
Six-month countdown to go-live for CTIS
The entry into application of the Clinical Trials Regulation and the go-live date for the Clinical Trials Information System (CTIS) will be on 31 January 2022
-
Update on safety of COVID-19 Vaccine Janssen
Update on safety of COVID-19 Vaccine Janssen
-
Update on safety of COVID-19 Vaccine Janssen
Update on safety of COVID-19 Vaccine Janssen
Following an EMA review, Guillain Barré syndrome (GBS) will be listed as a very rare side effect of COVID-19 Vaccine Janssen
